Taken together, this study for the first time elucidates that the Son-lipo alleviates ARDS by repairing the endothelial barrier and inactivating NLRP3 inflammasome, hence providing a promising strategy for the clinical treatment of ARDS. Here, NLRP3 is linked to acute respiratory distress syndrome.